6 Comments
User's avatar
KaiKai's avatar

Thx for this. In addition to healthy user bias, the pending observational studies will, like that of COVID vaccines, fail to account for concomitant mitigation measures.

Expand full comment
Michael Buratovich, Ph.D's avatar

Dave - we should start a campaign: “Free the Data!” Imagine how that would resonate through the halls!!!

Expand full comment
Hansang Bae's avatar

I hope you never learn to kowtow! Good for you.

Expand full comment
toolate's avatar

What are you some kind of a trump supporter one can already hear our medical colleague saying. What a brilliant tactic that became to label any solid evidence-based medicine approaches as being fascist

Expand full comment
Adrian Gaty's avatar

Thank you for this! To clarify, as some non medical readers might get confused, this is not the same thing as the new RSV therapeutic (not a real vaccine) the FDA approved this year for all babies to get, with rollout probably this month (the rep is coming to my clinic next week!).

This is way above my pay grade, but considering that 2 different RSV prophylactics are being launched the same year - the maternal vaccine above and the non vaccine product injected directly into the babies themselves - won’t that make it very very difficult to figure out which one works? Neither trial acknowledged the existence of the other. Is it necessary and/or safe to give the baby shot to a child whose mom got the maternal shot? Seems an odd coincidence of timing that will muddy a lot of waters, hopefully I’m wrong!

Expand full comment
mk's avatar

Are you concerned about Beyfortus? I asked my rep about overall change in LRTI and she just kept repeating LRT RSV disease was decreased, without addressing my concern that a child destined to have LRT disease will just wind up with another pathogen.

Expand full comment